By Bonnie Eslinger ( March 31, 2020, 7:44 PM BST) -- The Court of Appeal ruled Tuesday that Genentech Inc. can't correct a mistake made by one of its agents that will prematurely end its patent rights for an eye-disease treatment, saying accommodating the request would put the biotech company in a "uniquely privileged position."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.